Targeted therapy or "treatment goals" is the newest technology in the realm of cancer treatment. This therapy is fundamentally different from the classical methods of cancer treatment - surgery, radiotherapy and chemotherapy, because it causes the destruction of tumor cells exclusively, and has no adverse effects on healthy tissue; is non-toxic, and therefore does not come with the commonly expected side effects.
Targeted cancer therapy is based on the understanding of differences in the molecular mechanisms of the tumor and healthy tissue and development of drugs that directly affect the specific molecule which is associated with the growth of tumor cells. Therefore, it is used as a synonym for the second common name for this type of treatment - Molecular Targeted Therapy.
Targeted agents in this case are used in combination with classic chemotherapy.
Targeted therapy is used for the prevention cancer metastasis as well as for treatment of patients with advanced metastatic disease. In the past few years, the world has seen a number of new targeted therapies sprout, which are now becoming quite well-represented in the market. In addition, targeted therapies have a wide range of synergies as they tend to increase the effects of other drugs. Targeted agents in this case are used in combination with chemotherapy. This effect was used by our scientists to extend the period of remission in cancer patients. Sometimes the remission lasts up to several years.
For more details about the private targeted therapy can be found here: